Related Experiment Video
Updated: Aug 13, 2026
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and
Terese Karlsson1, Marie Lundholm2, Anders Widmark1
1Department of Radiation Sciences, Division of Oncology, Umeå University, Umeå, Sweden.
Abstract:
Skeletal metastatic disease is a deleterious consequence of dissemination of tumor cells from numerous primary sites, such as prostate, lung and breast. Skeletal metastases are still incurable, resulting in development of clinical complications and decreased survival for cancer patients with metastatic disease. During the last decade, tumor cell-derived microvesicles have been identified and suggested to be involved in cancer disease progression. Whether cancer exosomes are involved in tumor and bone cell interactions in the metastatic site is still, however, a rather unexplored field. Here we show that exosomes isolated from the murine prostate cancer cell line TRAMP-C1 dramatically decrease fusion and differentiation of monocytic osteoclast precursors to mature, multinucleated osteoclasts. The presence of tumor cell-derived exosomes also clearly decreased the expression of established markers for osteoclast fusion and differentiation, including DC-STAMP, TRAP, cathepsin K, and MMP-9. In contrast, exosomes derived from murine fibroblastic cells did not affect osteoclast formation. Our findings suggest that exosomes released from tumor cells in the tumor-bone interface are involved in pathological regulation of bone cell formation in the metastatic site. This further strengthens the role of tumor cell-derived microvesicles in cancer progression and disease aggressiveness.
Insights
Tumor cell exosomes hinder osteoclast formation, impacting bone remodeling in skeletal metastases. This discovery highlights exosomes
Area of Science:
- Oncology and Cell Biology
- Cancer Metastasis Research
- Bone Biology and Pathology
Background:
- Skeletal metastatic disease, a common complication of cancers like prostate, lung, and breast, remains incurable and leads to significant patient morbidity.
- Tumor cell-derived microvesicles, including exosomes, are increasingly recognized for their role in cancer progression.
- The specific involvement of exosomes in the interaction between tumor cells and bone cells at metastatic sites is not well understood.
Purpose of the Study:
- To investigate the role of prostate cancer cell-derived exosomes in osteoclast formation and differentiation.
- To determine if exosomes from tumor cells influence the interaction between tumor and bone cells at the metastatic site.
Main Methods:
- Isolation of exosomes from the murine prostate cancer cell line TRAMP-C1 and murine fibroblastic cells.
- Assessment of the effect of these exosomes on the fusion and differentiation of monocytic osteoclast precursors.
- Quantification of key osteoclast differentiation markers (DC-STAMP, TRAP, cathepsin K, MMP-9) via quantitative real-time PCR or Western blotting.
Main Results:
- Exosomes derived from TRAMP-C1 prostate cancer cells significantly inhibited the fusion and differentiation of osteoclast precursors into mature osteoclasts.
- The expression of critical osteoclast markers, including DC-STAMP, TRAP, cathepsin K, and MMP-9, was markedly reduced in the presence of tumor cell-derived exosomes.
- Exosomes from non-cancerous murine fibroblastic cells did not exhibit any inhibitory effect on osteoclast formation.
Conclusions:
- Exosomes released by prostate cancer cells actively interfere with normal osteoclastogenesis, suggesting a role in the pathological bone remodeling associated with skeletal metastases.
- These findings underscore the significance of tumor cell-derived exosomes in mediating tumor-bone interactions and potentially driving cancer progression and disease aggressiveness at metastatic sites.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
02:17The Tumor Microenvironment
01:19Mesenchymal Stem Cells